5-HT1A Receptor, an Old Target for New Therapeutic Agents

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 12, 2008-01 ,pp. : 1024-1034

Bentham Science Publishers

Access to resources Recommend Favorite

Schizophrenia Still an Area of Unmet Therapeutic Need: Possibility of New Therapies by 2007

By Adis International Limited  

Pharmaceutical & Diagnostic Innovation, Vol. 3, Iss. 8, 2005-01 ,pp. : 10-12

Adis International

Access to resources Recommend Favorite

Agents that target cysteine residues of biomolecules and their therapeutic potential

By Scozzafava A.   Mastrolorenzo A.   Supuran C.T.  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 5, 2001-05 ,pp. : 765-787

Informa Healthcare

Access to resources Recommend Favorite

Dual Ligands Targeting Dopamine D2 and Serotonin 5-HT1A Receptors as New Antipsychotical or Anti-Parkinsonian Agents

By  

Current Medicinal Chemistry, Vol. 21, Iss. 4, 2014-02 ,pp. : 437-457

Bentham Science Publishers

Access to resources Recommend Favorite

Inflammation in Atherosclerosis: A New Therapeutic Target

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 4, Iss. 3, 2005-06 ,pp. : 283-295

Bentham Science Publishers

Access to resources Recommend Favorite